Antidepressants and the risk of psoriasis induction: A case–control study

Background: Psoriasis (PSO) is a common chronic autoimmune skin disease with a significant psycho-socio-economic burden. Some antidepressants (ADs) such as fluoxetine and bupropion can induce or exacerbate PSO. This study aimed to investigate the correlation between ADs history before PSO onset, and...

Full description

Bibliographic Details
Main Authors: Seyedeh-Fatemeh Sadatmadani, Amir Hossein Siadat, Fariba Iraji, Fereshteh Alsahebfosoul
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2023-01-01
Series:Advanced Biomedical Research
Subjects:
Online Access:http://www.advbiores.net/article.asp?issn=2277-9175;year=2023;volume=12;issue=1;spage=16;epage=16;aulast=Sadatmadani
_version_ 1827783447900323840
author Seyedeh-Fatemeh Sadatmadani
Amir Hossein Siadat
Fariba Iraji
Fereshteh Alsahebfosoul
author_facet Seyedeh-Fatemeh Sadatmadani
Amir Hossein Siadat
Fariba Iraji
Fereshteh Alsahebfosoul
author_sort Seyedeh-Fatemeh Sadatmadani
collection DOAJ
description Background: Psoriasis (PSO) is a common chronic autoimmune skin disease with a significant psycho-socio-economic burden. Some antidepressants (ADs) such as fluoxetine and bupropion can induce or exacerbate PSO. This study aimed to investigate the correlation between ADs history before PSO onset, and the risk of PSO induction, in Isfahan province, Iran. Materials and Methods: In this case–control study, 80 patients with PSO were selected by non-probability sampling method, and 80 healthy individuals were selected using simple random sampling. They were interviewed and medical information was recorded. Chi-square, Mann–Whitney, and Kruskal–Wallis tests for dichotomous or categorical data, and independent-sample t test for continuous data were used. Statistical significance was taken as P ≤ 0.05. Results: In this case–control study, a total of 160 individuals, 80 participants in each group, were included. The mean age of the total samples was 44.8 ± 16 years. Forty-three percent of the individuals were women. PSO familial history in the cases was significantly higher than the control group (OR = 11.94, P = 0.001). It was revealed that use of ADs by patients before PSO induction, was greater than the controls (OR = 2.78, P = 0.058). Conclusions: Past history of ADs in the cases before PSO onset, was higher than the controls, indicating a possible association between ADs and the risk of PSO induction. This study can be effective to pay more attention to the possible complications of ADs and PSO risk factors. Accurate knowledge of PSO risk factors will be useful for better management and morbidity reduction.
first_indexed 2024-03-11T15:47:42Z
format Article
id doaj.art-1589ed5f3e654a04a2d4f62ee1662cd1
institution Directory Open Access Journal
issn 2277-9175
language English
last_indexed 2024-03-11T15:47:42Z
publishDate 2023-01-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Advanced Biomedical Research
spelling doaj.art-1589ed5f3e654a04a2d4f62ee1662cd12023-10-26T05:43:15ZengWolters Kluwer Medknow PublicationsAdvanced Biomedical Research2277-91752023-01-01121161610.4103/abr.abr_88_21Antidepressants and the risk of psoriasis induction: A case–control studySeyedeh-Fatemeh SadatmadaniAmir Hossein SiadatFariba IrajiFereshteh AlsahebfosoulBackground: Psoriasis (PSO) is a common chronic autoimmune skin disease with a significant psycho-socio-economic burden. Some antidepressants (ADs) such as fluoxetine and bupropion can induce or exacerbate PSO. This study aimed to investigate the correlation between ADs history before PSO onset, and the risk of PSO induction, in Isfahan province, Iran. Materials and Methods: In this case–control study, 80 patients with PSO were selected by non-probability sampling method, and 80 healthy individuals were selected using simple random sampling. They were interviewed and medical information was recorded. Chi-square, Mann–Whitney, and Kruskal–Wallis tests for dichotomous or categorical data, and independent-sample t test for continuous data were used. Statistical significance was taken as P ≤ 0.05. Results: In this case–control study, a total of 160 individuals, 80 participants in each group, were included. The mean age of the total samples was 44.8 ± 16 years. Forty-three percent of the individuals were women. PSO familial history in the cases was significantly higher than the control group (OR = 11.94, P = 0.001). It was revealed that use of ADs by patients before PSO induction, was greater than the controls (OR = 2.78, P = 0.058). Conclusions: Past history of ADs in the cases before PSO onset, was higher than the controls, indicating a possible association between ADs and the risk of PSO induction. This study can be effective to pay more attention to the possible complications of ADs and PSO risk factors. Accurate knowledge of PSO risk factors will be useful for better management and morbidity reduction.http://www.advbiores.net/article.asp?issn=2277-9175;year=2023;volume=12;issue=1;spage=16;epage=16;aulast=Sadatmadaniantidepressantsautoimmune dermatologic diseasedepressionpsoriasis
spellingShingle Seyedeh-Fatemeh Sadatmadani
Amir Hossein Siadat
Fariba Iraji
Fereshteh Alsahebfosoul
Antidepressants and the risk of psoriasis induction: A case–control study
Advanced Biomedical Research
antidepressants
autoimmune dermatologic disease
depression
psoriasis
title Antidepressants and the risk of psoriasis induction: A case–control study
title_full Antidepressants and the risk of psoriasis induction: A case–control study
title_fullStr Antidepressants and the risk of psoriasis induction: A case–control study
title_full_unstemmed Antidepressants and the risk of psoriasis induction: A case–control study
title_short Antidepressants and the risk of psoriasis induction: A case–control study
title_sort antidepressants and the risk of psoriasis induction a case control study
topic antidepressants
autoimmune dermatologic disease
depression
psoriasis
url http://www.advbiores.net/article.asp?issn=2277-9175;year=2023;volume=12;issue=1;spage=16;epage=16;aulast=Sadatmadani
work_keys_str_mv AT seyedehfatemehsadatmadani antidepressantsandtheriskofpsoriasisinductionacasecontrolstudy
AT amirhosseinsiadat antidepressantsandtheriskofpsoriasisinductionacasecontrolstudy
AT faribairaji antidepressantsandtheriskofpsoriasisinductionacasecontrolstudy
AT fereshtehalsahebfosoul antidepressantsandtheriskofpsoriasisinductionacasecontrolstudy